PLEASANTON, Calif., April 03, 2017 -- Title21 Health Solutions (www.Title21.com), a provider of Enterprise Quality Management Software and Cell Therapy Software solutions to help health science organizations improve quality and patient outcomes announces that it is certified by the Small Business Association (SBA) as a Woman-Owned Small Business (WOSB).
WOSB certification signifies that a company is at least 51% woman-owned and is a small business per the SBA’s requirements. WOSB certification enables Title21 Health Solutions to satisfy WOSB federal contracting requirements and meet the specifications of government agencies, institutions and corporations who work to establish diversity in purchasing and vendor relations.
Title21 Health Solutions is led by Chief Executive Officer and President, Lynn Fischer, and over half of its employees are women. “We are thrilled that Title21 Health Solutions’ official certification as a Woman-Owned Small Business will expand our opportunities and support our customers to an even greater extent by helping them meet their supplier diversity initiatives,” stated Fischer. “I am honored to be at the helm of a progressive and innovative company and among those who can inspire other women to pursue STEM and leadership positions in tech.”
About Title21 Health Solutions
Title21 Health Solutions continues to gain national recognition for its innovative technology that is able to help hospitals, biotechnology, regenerative medicine and other health science organizations improve quality, efficiency and patient safety. Title21’s product line includes web-based quality management solutions and the most comprehensive cellular therapy software available in the market. Learn more about Title21 Health Solutions at www.Title21.com.
Media Contact Haley Roebuck | [email protected]


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



